cancer
New drug class could treat range of cancers with faulty BRCA genes
Posted in Medicine on 2nd Jul, 2021
by Alex Muller
Scientists at The Institute of Cancer Research, London, and the pharmaceutical company Artios, explored the potential of using POLQ inhibitors in treating cancer cells with defects in the BRCA genes.
Lung cancer patients should be screened for MET oncogene amplification, research suggests
Posted in Medicine on 2nd Jul, 2021
by Alex Muller
"Our study suggests that patients with a MET oncogene amplification will not respond to immunotherapy alone and will require treatment with a combination of a MET inhibitor together with immunotherapy,"
Cancer research: What’s exciting the experts?
Posted in Medicine on 2nd Jul, 2021
by Alex Muller
Medical News Today spoke with a group of scientists and clinicians who specialize in the field.
Cancer Research UK partners with Aleta Biotherapeutics on blood cancer therapy
Posted in Medicine on 2nd Jul, 2021
by Alex Muller
“There is an urgent need to develop new therapies that can help people with B-cell cancers, such as lymphoma and leukaemia, whose cancer has progressed after treatment with CD19 CAR-T cell therapy,”
Takeda Reports Promising Results For Lung Cancer Treatment
Posted in Medicine on 2nd Jul, 2021
by Alex Muller
Mobocertinib is the first small-molecule TKI specifically designed to selectively target EGFR Exon20 insertions in patients with mNSCLC and demonstrated clinical proof-of-concept in these patients.